2021-06-10T00:00:00.000+10:00
Ongoing
CPOST
CPOST
Skin cancer
A randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma.
A randomized, Placebo-Controlled, Double-Blind Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma.
Trial overview
Clinical Area
Medical Oncology
Disease / Condition
Skin
Study Phase
III |
Trial Identifiers
Registration number: NCT03969004 https://www.clinicaltrials.gov/study/NCT03969004
|
GenesisCare Location(s)
GenesisCare Bundaberg (Oncology)
GenesisCare Bundaberg (Oncology)
:::
GenesisCare Tugun (Oncology)
GenesisCare Tugun (Oncology)
:::
Principal Investigator(s)